Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Vasopressin

Vasopressin, also known as antidiuretic hormone (ADH), is a peptide hormone synthesized in the hypothalamus and secreted by the posterior pituitary gland. It regulates water balance and blood pressure by promoting water reabsorption in the kidneys and constric

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Vasopressin, also known as antidiuretic hormone (ADH), is a peptide hormone synthesized in the hypothalamus and secreted by the posterior pituitary gland. It regulates water balance and blood pressure by promoting water reabsorption in the kidneys and constricting blood vessels. Widely used in medicine, Vasopressin and its synthetic analogs, such as desmopressin, treat conditions like diabetes insipidus, septic shock, and esophageal variceal bleeding. With a short plasma half-life, it requires precise dosing to balance therapeutic benefits with potential risks like hyponatremia. Its multifaceted roles in physiology and clinical practice make Vasopressin a significant focus of medical research.

Category

Peptide Hormone

Sequence

H-Cys(1)-Tyr-Phe-Gln-Asn-Cys(1)-Pro-Arg-Gly-NH2

Molecular Weight

Approximately 1084.23 g/mol

Molecular Formula

C46H65N15O12S2

Half Life

Approximately 10–20 minutes

Most Common Uses

Vasopressin is a peptide hormone used in medicine to regulate water balance and blood pressure. It is commonly employed to treat diabetes insipidus, a condition causing excessive thirst and urination, by using synthetic forms like desmopressin to help kidneys reabsorb water and reduce urine output. In septic shock, where blood pressure drops significantly, Vasopressin serves as a vasopressor, constricting blood vessels to stabilize circulation when other treatments are insufficient. It also helps manage bleeding from esophageal varices, often linked to liver disease, by reducing blood flow to the affected area, aiding in hemorrhage control.

In cardiac arrest, Vasopressin may be used during resuscitation to improve blood flow to the heart and brain by constricting peripheral vessels. Additionally, it is used in diagnostic tests, such as the water deprivation test, to evaluate pituitary and kidney function, helping distinguish causes of excessive urination. These diverse applications demonstrate Vasopressin’s importance in treating hormonal imbalances and urgent medical conditions.

Mechanism of Action

Vasopressin exerts its effects through specific receptors in various tissues to regulate water balance and blood pressure. It primarily binds to V2 receptors in the kidneys, stimulating the insertion of aquaporin-2 water channels into the collecting duct cells, which increases water reabsorption and concentrates urine, helping maintain body fluid balance. Vasopressin also interacts with V1 receptors on vascular smooth muscle cells, causing vasoconstriction that elevates blood pressure, particularly in conditions like septic shock. It also acts on V1b receptors in the pituitary gland to modulate adrenocorticotropic hormone (ACTH) release, influencing stress responses. Through these receptor-mediated actions, Vasopressin effectively supports the body’s ability to conserve water and stabilize circulation, playing a significant role in maintaining physiological balance under varying conditions.

Structure and Pharmacology

Vasopressin is a peptide hormone with a well-defined structure consisting of 9 amino acids in the sequence H-Cys(1)-Tyr-Phe-Gln-Asn-Cys(1)-Pro-Arg-Gly-NH2. A critical disulfide bond between the two cysteine residues at positions one and six forms a cyclic structure, which enhances the molecule’s stability and enables effective binding to its receptors. This compact, cyclic configuration distinguishes Vasopressin from other peptide hormones and allows it to interact efficiently with target tissues, such as the kidneys and blood vessels, to regulate water retention and vascular tone. The amidated glycine at the C-terminus further contributes to its structural integrity, ensuring proper function in physiological processes.

Pharmacologically, Vasopressin is frequently administered as synthetic analogs, such as desmopressin or terlipressin, which are designed to replicate its effects while offering improved stability and a longer duration of action. These analogs primarily target V2 receptors in the renal collecting ducts to promote water reabsorption, making them effective for treating conditions like diabetes insipidus, where patients experience excessive urination and thirst. They also act on V1 receptors in vascular smooth muscle to induce vasoconstriction, which is beneficial in managing hypotensive states like septic shock or controlling bleeding from esophageal varices.

Vasopressin has a plasma half-life of approximately 10–20 minutes, as it is rapidly broken down by peptidases in the liver and kidneys. This short half-life necessitates careful dosing, often via intravenous or intranasal routes, to achieve sustained effects in clinical settings. The precise metabolism of Vasopressin allows for tailored therapeutic applications, balancing its roles in fluid homeostasis and blood pressure regulation.

Warnings and Cautions

Vasopressin requires careful administration due to its potent effects on water retention and blood vessel constriction. Excessive dosing, particularly with synthetic analogs like desmopressin, can lead to water overload, resulting in hyponatremia, a condition characterized by low blood sodium levels that may cause symptoms ranging from headache and nausea to seizures in severe cases. Patients with heart failure or kidney impairment need close monitoring, as Vasopressin’s ability to increase water reabsorption and constrict vessels can exacerbate fluid retention or strain circulation.

Allergic reactions, though rare, have been reported with vasopressin use, necessitating immediate discontinuation if signs like rash or difficulty breathing occur. In septic shock or variceal bleeding, prolonged high doses may reduce blood flow to organs, potentially leading to complications such as tissue ischemia. The short half-life of Vasopressin requires precise dosage adjustments, and patients should be monitored for side effects such as abdominal cramps or chest pain, especially during intravenous administration. Special caution is advised in elderly patients or those with a history of cardiovascular issues, as Vasopressin can elevate blood pressure significantly.

Research & Clinical Trials

Vasopressin Loading for Septic Shock

Vasopressin and Kidney Water Balance

The study showed that the hormone Vasopressin is the body’s main regulator of water balance, working through a “water channel” protein in the kidneys called aquaporin-2 (AQP2). When the body gets dehydrated or sodium levels rise, Vasopressin is released and tells the kidneys to move AQP2 channels to the surface of kidney cells. This allows water to be reabsorbed back into the body instead of being lost in urine. Once the body’s water and salt balance is restored, Vasopressin levels drop, and the AQP2 channels are pulled back inside the cells, stopping water reabsorption.

Vasopressin & Body Fluid Levels

Sourcing

USA

LIMITLESS LIFE NOOTROPICS aka Biotech

Use Discount Code: EP20

SCANTIFIX

Use Discount Code: Exploringpeptides

Canada

BIOSLAB

Use Discount Code: EP10

Europe

DNLABResearch

Use Discount Code: EP15

Australia

LVLUPHEALTH

References

[1] Nakamura, K., Nakano, H., Ikechi, D. et al. The Vasopressin Loading for Refractory septic shock (VALOR) study: a prospective observational study. Crit Care 27, 294 (2023). https://doi.org/10.1186/s13054-023-04583-7

[2] Boone, M., & Deen, P. M. (2008). Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption. Pflugers Archiv : European journal of physiology, 456(6), 1005–1024. https://doi.org/10.1007/s00424-008-0498-1

[3] Cuzzo B, Padala SA, Lappin SL. Physiology, Vasopressin. [Updated 2023 Aug 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526069/

Related articles

SLU-PP-915: Benefits, Research & Comparison with SLU-PP-332

Adalank vs Selank: Differences, Benefits and Effects

Adamax vs Semax: Comparison, Benefits, and Effects

Common Mistakes When Reconstituting Peptides

Peptides Vs Proteins: What’s The Difference?

What Are Peptides and How Do They Work?

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What are the dosages of vasopressin?

Injection Solution for Dilution

Source: www.medicinenet.com ↗
02What Recent Research Adds

Recent studies have refined rather than fundamentally changed the current understanding of monogamy. A 2025 study showed that monogamy influences reproductive investment in animal models, supporting the concept that mating systems leave measurable evolutionary signatures. Earlier studies published in 2024 identified epigenetic changes associated with pair bonding instead of a single biological mechanism underlying monogamy. A study published in Scientific Reports used seed beetles to show that monogamy influences investment in reproductive tissues under intense sexual selection, providing further insight into the evolutionary costs and benefits of monogamy across species. Together, these animal studies help researchers identify the evolutionary pressures that shape pair-bonding systems, while highlighting that such findings cannot be directly applied to humans. Rather, they provide insights into how pair bonding evolves across species.

Source: www.medscape.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →